According to bluebird bio 's latest financial reports and stock price the company's current number of shares outstanding is 109,098,000. At the end of 2023 the company had 109,098,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | 28.08% |
2022 | 85.18 M | 17.5% |
2021 | 72.49 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Sanofi SNY | 2,507,200,000 | 2,198.12% | ๐ซ๐ท France |
Merck MRK | 2,554,166,667 | 2,241.17% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | 177,171,000 | 62.40% | ๐บ๐ธ USA |
Acceleron Pharma XLRN | 53,824,600 | -50.66% | ๐บ๐ธ USA |
GlycoMimetics
GLYC | 64,349,709 | -41.02% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 72.52% | ๐บ๐ธ USA |